Stock 600671 HANGZHOU TIANMUSHAN PHARMACEUTICAL ENTERPRISE CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd

Equities

600671

CNE000000BF3

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
8.36 CNY -0.59% Intraday chart for Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd -9.33% -28.30%
2023 Qingdao Yuanjia Medical Treatment Technology proposal of Adding Sheng Xiaofan to the Company's Eleventh Board of Directors to Hangzhou TianMuShan Pharmaceutical Enterprise was approved. CI
2023 On October 19, 2023 Qingdao Yuanjia Medical Treatment Technology propose of Adding Sheng Xiaofan to the Company's Eleventh Board of Directors to Hangzhou TianMuShan Pharmaceutical Enterprise. CI

Business Summary

Hangzhou TianMuShan Pharmaceutical Enterprise Co., Ltd is a China based company principally engaged in the research and development, production and sales of pharmaceuticals and related health products. The Company is mainly engaged in the manufacture of chemical drug substances, processing of Chinese herbal pieces as well as the manufacture of traditional Chinese medicine preparation and Western medicine. The Company's main products are bright eye drops, FufangXianzhuliYe, amoxicillin and clavulanate potassium tablets, Hechedazao Jiaonang, Liu Wei Di Huang oral liquid, menthol, and peppermint oil. The Company mainly operates its business in the domestic market.

Number of employees: 371

Sales per Business

CNY in Million2021Weight2022Weight Delta
Drugs-Circulation Commodities
36.8 %
46 31.3 % 40 36.8 % -12.90%
Raw Materials
31.9 %
51 34.5 % 35 31.9 % -31.39%
Western Medicine
9.9 %
3 1.9 % 11 9.9 % +279.40%
Other
7.6 %
10 7.0 % 8 7.6 % -19.33%
Traditional Chinese Medicine
7.2 %
34 23.1 % 8 7.2 % -76.94%
Health Products
5.8 %
3 1.9 % 6 5.8 % +124.01%
Other Business
0.9 %
1 0.4 % 1 0.9 % +80.85%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
100.0 %
147 100.0 % 109 100.0 % -25.95%

Managers

Managers TitleAgeSince
Xu Yu Xu CEO
 Chief Executive Officer 46 23-09-26
Hong Jian Yu DFI
 Director of Finance/CFO 46 23-09-26
Guo Jun Dang BRD
 Director/Board Member 37 21-05-25
Hua Cheng BRD
 Director/Board Member 55 91-12-31
Guo Xun Chen IRC
 Investor Relations Contact 42 -

Members of the board

Members of the board TitleAgeSince
Hua Cheng BRD
 Director/Board Member 55 91-12-31
Guo Jun Dang BRD
 Director/Board Member 37 21-05-25
Hong Jian Yu DFI
 Director of Finance/CFO 46 23-09-26
Jia Yong Liu CHM
 Chairman 46 23-10-12
Jun De Huang BRD
 Director/Board Member 38 23-09-04
Shi Bin Liu BRD
 Director/Board Member 38 -
Yun Song Jia BRD
 Director/Board Member 42 23-10-29
Xiao Meng Sheng BRD
 Director/Board Member 54 23-10-29
Yang Pei BRD
 Director/Board Member 40 21-05-25
Lu Wang BRD
 Director/Board Member 31 23-05-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 121,778,885 47,149,631 ( 38.72 %) 0 38.72 %

Shareholders

NameEquities%Valuation
Maxwealth Fund Management Co., Ltd.
0.0344 %
41,900 0.0344 % 52 988 ¥

Company contact information

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.

Room 1803-1804, Boya Times Center Yingfeng Street, Shixin North Road

311200, Hangzhou

+

http://www.hztmyy.com
address Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd(600671)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
HANGZHOU TIANMUSHAN PHARMACEUTICAL ENTERPRISE CO.,LTD Stock Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd
-28.30% 141M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+27.97% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+23.66% 550B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.02% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.85% 317B
ABBVIE INC. Stock AbbVie Inc.
+6.25% 292B
ASTRAZENECA PLC Stock AstraZeneca PLC
+2.30% 211B
NOVARTIS AG Stock Novartis AG
-0.28% 203B
PFIZER, INC. Stock Pfizer, Inc.
-11.81% 144B
AMGEN INC. Stock Amgen Inc.
-8.80% 141B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600671 Stock
  4. Company Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd